Figure 5: Conolidine is antinociceptive in visceral, tonic and persistent suffering types and is also present at micromolar concentrations within the brain immediately after systemic injection. Conolidine CONOCB2™ effectively is effective by making a barrier concerning the opioid receptors within the brain plus the "scavenger" receptors in the body, https://davidk582ztf9.vblogetin.com/profile